HighTower Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$71.3M Sell
145,001
-38
-0% -$20.6K 0.08% 263
2025
Q4
$84M Sell
145,039
-1,216
-0.8% -$688K 0.09% 224
2025
Q3
$70.9M Buy
146,255
+2,143
+1% +$997K 0.08% 247
2025
Q2
$58.4M Sell
144,112
-35,272
-20% -$14.7M 0.07% 278
2025
Q1
$89.3M Buy
179,384
+1,714
+1% +$928K 0.12% 181
2024
Q4
$92.4M Sell
177,670
-4,780
-3% -$2.63M 0.13% 168
2024
Q3
$113M Buy
182,450
+6,609
+4% +$3.91M 0.16% 144
2024
Q2
$97.4M Sell
175,841
-3,695
-2% -$2.12M 0.15% 152
2024
Q1
$104M Buy
179,536
+4,767
+3% +$2.67M 0.17% 135
2023
Q4
$93M Sell
174,769
-10,400
-6% -$5.03M 0.16% 140
2023
Q3
$94.4M Buy
185,169
+29,609
+19% +$15.8M 0.18% 125
2023
Q2
$81.3M Buy
155,560
+34,689
+29% +$18.7M 0.16% 135
2023
Q1
$69.6M Sell
120,871
-340
-0.3% -$192K 0.15% 157
2022
Q4
$66.8M Buy
121,211
+2,850
+2% +$1.51M 0.15% 148
2022
Q3
$60.3M Buy
118,361
+89
+0.1% +$49.8K 0.16% 142
2022
Q2
$64.3M Buy
118,272
+589
+0.5% +$324K 0.17% 131
2022
Q1
$69.5M Buy
117,683
+193
+0.2% +$111K 0.15% 138
2021
Q4
$78.4M Buy
117,490
+37,615
+47% +$23.5M 0.17% 130
2021
Q3
$45.6M Buy
79,875
+5,798
+8% +$3.18M 0.12% 173
2021
Q2
$37.7M Buy
74,077
+2,691
+4% +$1.27M 0.11% 193
2021
Q1
$32.5M Sell
71,386
-1,899
-3% -$906K 0.1% 200
2020
Q4
$34.1M Buy
73,285
+11,766
+19% +$5.52M 0.14% 142
2020
Q3
$27.1M Buy
61,519
+3,520
+6% +$1.45M 0.13% 165
2020
Q2
$21M Sell
57,999
-3,734
-6% -$1.25M 0.11% 185
2020
Q1
$17.5M Buy
61,733
+1,885
+3% +$594K 0.11% 186
2019
Q4
$19.5M Sell
59,848
-1,353
-2% -$410K 0.12% 198
2019
Q3
$17.8M Sell
61,201
-337
-0.5% -$96.5K 0.1% 215
2019
Q2
$18.1M Buy
61,538
+4,554
+8% +$1.25M 0.11% 202
2019
Q1
$15.6M Buy
56,984
+1,291
+2% +$321K 0.1% 209
2018
Q4
$12.4M Sell
55,693
-1,386
-2% -$325K 0.1% 218
2018
Q3
$13.9M Sell
57,079
-1,571
-3% -$361K 0.1% 221
2018
Q2
$12.1M Buy
58,650
+2,853
+5% +$606K 0.09% 238
2018
Q1
$11.5M Buy
55,797
+777
+1% +$163K 0.1% 233
2017
Q4
$10.4M Sell
55,020
-7,000
-11% -$1.34M 0.09% 256
2017
Q3
$11.7M Buy
62,020
+2,523
+4% +$457K 0.1% 216
2017
Q2
$10.4M Buy
59,497
+6,325
+12% +$1.06M 0.09% 238
2017
Q1
$8.17M Buy
53,172
+8,871
+20% +$1.36M 0.08% 277
2016
Q4
$6.27M Buy
44,301
+7,156
+19% +$1.06M 0.07% 308
2016
Q3
$5.91M Sell
37,145
-1,994
-5% -$307K 0.07% 311
2016
Q2
$5.79M Sell
39,139
-14,997
-28% -$2.21M 0.07% 281
2016
Q1
$7.68M Sell
54,136
-2,157
-4% -$289K 0.03% 254
2015
Q4
$8.01M Buy
56,293
+7,986
+17% +$1.07M 0.1% 226
2015
Q3
$5.9M Sell
48,307
-1,275
-3% -$166K 0.08% 278
2015
Q2
$6.43M Buy
49,582
+9,580
+24% +$1.25M 0.1% 217
2015
Q1
$5.34M Buy
40,002
+9,174
+30% +$1.18M 0.08% 270
2014
Q4
$3.86M Sell
30,828
-5,245
-15% -$638K 0.06% 349
2014
Q3
$4.39M Buy
36,073
+1,327
+4% +$161K 0.07% 299
2014
Q2
$4.1M Sell
34,746
-2,173
-6% -$256K 0.07% 301
2014
Q1
$4.42M Sell
36,919
-6,223
-14% -$740K 0.09% 265
2013
Q4
$4.8M Buy
43,142
+1,106
+3% +$110K 0.1% 240
2013
Q3
$3.87M Buy
42,036
+771
+2% +$69.7K 0.1% 239
2013
Q2
$3.49M Buy
+41,265
New +$3.44M 0.1% 247

Other funds holding TMO

HighTower Advisors's TMO Position: Q1 2026 in Review

HighTower Advisors reduced its Thermo Fisher Scientific (TMO) stake by 0.03% in Q1 2026, selling an estimated $20.6K and leaving 145,001 shares worth $71.3M. The position accounts for 0.08% of the portfolio, ranked #263.

HighTower Advisors first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $113M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • HighTower Advisors held 145,001 shares of Thermo Fisher Scientific worth $71.3M as of Q1 2026.
  • HighTower Advisors sold 38 Thermo Fisher Scientific shares in Q1 2026, an estimated $20.6K.
  • Thermo Fisher Scientific made up 0.08% of HighTower Advisors's portfolio in Q1 2026, its #263 holding.
  • HighTower Advisors first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
  • HighTower Advisors's Thermo Fisher Scientific position peaked at $113M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on HighTower Advisors's 13F filing for Q1 2026, filed 5 May 2026.